205 related articles for article (PubMed ID: 24478190)
1. Discomfort assessment in peripheral angiography: randomized clinical trial of Iodixanol 270 versus Ioversol 320 in diabetics with critical limb ischemia.
Palena LM; Sacco ZD; Brigato C; Sultato E; Barra D; Candeo A; Manzi M
Catheter Cardiovasc Interv; 2014 Nov; 84(6):1019-25. PubMed ID: 24478190
[TBL] [Abstract][Full Text] [Related]
2. Iso-osmolar contrast (iodixanol) reduces patient and operator pain during peripheral angiography.
Ortiz-Lopez C; Prasad A
Catheter Cardiovasc Interv; 2014 Nov; 84(6):1026-7. PubMed ID: 25352194
[No Abstract] [Full Text] [Related]
3. Patient Discomfort during Carotid Artery Stenting: A Comparison Study between Iodixanol versus Iopamidol.
Borrelli MP; Setacci F; de Donato G; Galzerano G; Benevento D; Mele M; Rosadini D; Messina G; Setacci C
Ann Vasc Surg; 2017 Feb; 39():167-172. PubMed ID: 27521830
[TBL] [Abstract][Full Text] [Related]
4. Automated Carbon Dioxide Angiography for the Evaluation and Endovascular Treatment of Diabetic Patients With Critical Limb Ischemia.
Palena LM; Diaz-Sandoval LJ; Candeo A; Brigato C; Sultato E; Manzi M
J Endovasc Ther; 2016 Feb; 23(1):40-8. PubMed ID: 26567126
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
Weiland FL; Marti-Bonmati L; Lim L; Becker HC
Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
[TBL] [Abstract][Full Text] [Related]
6. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
[TBL] [Abstract][Full Text] [Related]
7. Randomized, Double-Blind Study Comparing Patient Comfort and Safety Between Iodixanol 320 mg I/mL and Iopamidol 370 mg I/mL in Patients Undergoing Peripheral Arteriography - The COMFORT II Trial.
Rosenberg C; Martínez-Rodrigo JJ; Lonjedo Vicent E; Macho J; Lim L; Todoran TM;
J Invasive Cardiol; 2017 Jan; 29(1):9-15. PubMed ID: 28045670
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
[TBL] [Abstract][Full Text] [Related]
9. Patient discomfort associated with the use of intra-arterial iodinated contrast media: a meta-analysis of comparative randomized controlled trials.
McCullough PA; Capasso P
BMC Med Imaging; 2011 May; 11():12. PubMed ID: 21609484
[TBL] [Abstract][Full Text] [Related]
10. Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide.
Justesen P; Downes M; Grynne BH; Lang H; Rasch W; Seim E
Cardiovasc Intervent Radiol; 1997; 20(4):251-6. PubMed ID: 9211770
[TBL] [Abstract][Full Text] [Related]
11. Pain in femoral arteriography. A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers.
Manke C; Marcus C; Page A; Puey J; Batakis O; Fog A
Acta Radiol; 2003 Nov; 44(6):590-6. PubMed ID: 14616202
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
[TBL] [Abstract][Full Text] [Related]
13. Immediate and delayed hypersensitivity after intra-arterial injection of iodinated contrast media: a prospective study in patients with coronary angiography.
Sohn KH; Kim GW; Lee SY; Kim HS; Cho SH; Han JK; Kang HR
Eur Radiol; 2019 Oct; 29(10):5314-5321. PubMed ID: 30937592
[TBL] [Abstract][Full Text] [Related]
14. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
15. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
Karlsberg RP; Dohad SY; Sheng R;
J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
[TBL] [Abstract][Full Text] [Related]
16. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of ioversol. A metaanalysis of 57 randomized, double-blind clinical trials.
Floriani I; Ciceri M; Torri V; Tinazzi A; Jahn H; Noseda A
Invest Radiol; 1996 Aug; 31(8):479-91. PubMed ID: 8854194
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
19. Long-term mortality after invasive diagnostic and endovascular revascularization in PAD patients.
Broich EM; Reinecke H; Malyar NM; Meyborg M; Gebauer K
Int Angiol; 2016 Oct; 35(5):516-25. PubMed ID: 26406964
[TBL] [Abstract][Full Text] [Related]
20. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.
Hernández F; Mora L; García-Tejada J; Velázquez M; Gómez-Blázquez I; Bastante T; Albarrán A; Andreu J; Tascón J
Rev Esp Cardiol; 2009 Dec; 62(12):1373-80. PubMed ID: 20038403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
